Skip to content

The Cognitive Neural Mechanisms and Neuroregulatory Interventions of Realistic Creative Problem-solving Under the Effects of Drug Addiction

The Cognitive Neural Mechanisms and Neuroregulatory Interventions of Realistic Creative Problem-solving Under the Effects of Drug Addiction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06917534
Enrollment
80
Registered
2025-04-08
Start date
2023-11-23
Completion date
2024-08-15
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Addiction

Keywords

heroin, creative problem solving, divergent thinking, group problem solving

Brief summary

Drug addiction persists as a significant global social concern with a negative impact on social harmony and stability that cannot be ignored. After returning to society, individuals with drug addiction often suffer from impaired creative problem-solving abilities and difficulties in interpersonal cooperation. The difficulties in survival stress and the sense of helplessness triggered by these factors are important reasons that lead them to seek drugs repeatedly and even to commit criminal behaviors. Therefore, enhancing creative realistic problem-solving abilities emerges as a pivotal pathway for drug addicts to facilitate rehabilitation from drug addiction and achieve societal adaptation. The project emphasizes both individual and collaborative creative solution generation for realistic problem solving. The abnormal cognitive neural mechanisms and interpersonal neural mechanisms will be systematically explored by using multiple cognitive and neuroimaging methods, such as functional near-infrared spectroscopy (fNIRS), electroencephalography (EEG), and eye-tracking. From the cognitive-behavioral-brain level, a comprehensive neurophysiological multimodal predictive model of how drug addiction affects creative realistic problem-solving will be constructed by multi-level data fitting modeling. Building upon this research foundation, The investigators will further implement single and repeated sessions of transcranial direct current stimulation (tDCS) targeting damaged brain regions for the intervention of individual and collaborative problem-solving ability under the effect of drug addiction. The indicators of brain, cognition, and behavior will be tracked at multiple time points.

Interventions

DEVICETranscranial direct current stimulation

The participant cohort recruited for this study consists of individuals with drug addiction specifically those addicted to drugs. During the intervention phase, this group will adhere to a strict non-pharmacological intervention protocol, meaning they will not receive any form of pharmacotherapy, neurosurgical intervention, or other neuromodulation-based cognitive interventions, including but not limited to techniques such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). This design aims to ensure the internal validity of the study results and to exclude potential confounding effects of other interventions on neuroplasticity and cognitive function.

Sponsors

Nanyang Technological University
CollaboratorOTHER
Yifan Wang
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 30 and 60 years; * fulfilling the diagnostic criteria for severe substance use disorder as specified in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders. * a history of heroin use exceeding ten years, with a daily average intake of at least 0.1 grams. * abstinence duration of eight months or less, with a positive result of a urine test before entering the rehabilitation center. * no history of neuromodulation treatments such as tDCS within the past six months.

Exclusion criteria

* a history of alcohol dependence, neurological disorders, or other complex psychiatric conditions. * the presence of intracranial metallic implants or elevated intracranial pressure. * a history of epilepsy or recent electroencephalogram evidence of epileptiform activity. * the use of implanted electronic devices, such as pacemakers;. * scalp hyperalgesia or a tendency toward bleeding. * severe cardiac conditions.

Design outcomes

Primary

MeasureTime frameDescription
Score on the Group Alternative Use TaskFrom enrollment to the end of treatment at 1 monthUsed to measure collaborative problem-solving
Score on the Realistic Presented Problem TaskFrom enrollment to the end of treatment at 1 monthUsed to measure problem-solving ability individual creative problem-solving
Score on the Group Realistic Problem Solving TaskFrom enrollment to the end of treatment at 1 monthUsed to measure collaborative problem-solving ability
Cortical activation from fNIRSFrom enrollment to the end of treatment at 1 month
Cortical functional connectivity from fNIRSFrom enrollment to the end of treatment at 1 month
Inter-brain neural synchronization from fNIRS hyperscaningFrom enrollment to the end of treatment at 1 month
Pupil response from eye-trackingFrom enrollment to the end of treatment at 1 month
Score on the Alternative Use TaskFrom enrollment to the end of treatment at 1 monthUsed to measure the individual problem-solving ability

Secondary

MeasureTime frameDescription
Score on the Wsiconsin Card Sorting Test (WCST)From enrollment to the end of treatment at 1 monthUsed to measure cognitive flexibility.
Score on the Chain Free Association TaskFrom enrollment to the end of treatment at 1 monthUsed to measure remote associative ability.
Score on the Verbal Fluency TaskFrom enrollment to the end of treatment at 1 monthUsed to measure remote association ability
Average fixation duration from eye-trakingFrom enrollment to the end of treatment at 1 month
Fixation time percentage from eye-trakingFrom enrollment to the end of treatment at 1 month
Score on the joint drawing taskFrom enrollment to the end of treatment at 1 monthUsed to measure collaborative problem-solving from the perspective of social interaction.
Score on the Divergent Association TaskFrom enrollment to the end of treatment at 1 monthused to measure the divergent Association ability

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026